17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment
暂无分享,去创建一个
A. Ratto | Roberto Würth | A. Bajetto | T. Florio | F. Barbieri | A. Pattarozzi | R. Favoni | Alessandra Pattarozzi | Tullio Florio | Monica Gatti | Adriana Bajetto | Carola Porcile | Federica Barbieri | Roberto Würth | Gianluigi Lunardi | Alessandra Ratto | Roberto Favoni | Angelo Ferrari | C. Porcile | Monica Gatti | A. Ferrari | G. Lunardi
[1] M. Shupnik,et al. Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. , 2007, Molecular endocrinology.
[2] Kathryn E Luker,et al. Functions of CXCL12 and CXCR4 in breast cancer. , 2006, Cancer letters.
[3] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[4] R. Nicholson,et al. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells , 2006, Breast Cancer Research and Treatment.
[5] M. Robello,et al. Chemokine Stromal Cell-Derived Factor 1α Induces Proliferation and Growth Hormone Release in GH4C1 Rat Pituitary Adenoma Cell Line through Multiple Intracellular Signals , 2006, Molecular Pharmacology.
[6] N. Warrington,et al. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. , 2005, Cancer research.
[7] R. Clarke,et al. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12. , 2005, Carcinogenesis.
[8] R. Bonavia,et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.
[9] A. Sahin,et al. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. , 2005, Cancer research.
[10] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[11] G. Watkins,et al. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer , 2005, Breast Cancer Research.
[12] Sheng-Bin Peng,et al. Akt Activation, but not Extracellular Signal–Regulated Kinase Activation, Is Required for SDF-1α/CXCR4–Mediated Migration of Epitheloid Carcinoma Cells , 2005, Molecular Cancer Research.
[13] R. Schiff,et al. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. , 2005, Clinical Cancer Research.
[14] Masahiro Fukuoka,et al. Gefitinib — a novel targeted approach to treating cancer , 2004, Nature Reviews Cancer.
[15] D. Piwnica-Worms,et al. CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.
[16] G. Hortobagyi,et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. , 2004, Cancer cell.
[17] F. Balkwill. The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.
[18] Mette M. Rosenkilde,et al. Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor , 2004, Journal of Biological Chemistry.
[19] M. Campiglio,et al. Biologic and therapeutic role of HER2 in cancer , 2003, Oncogene.
[20] K. Korach,et al. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. , 2003, Molecular endocrinology.
[21] R. Bonavia,et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. , 2003, Cancer research.
[22] R. Bonavia,et al. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. , 2003, Toxicology letters.
[23] Allan H Friedman,et al. Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] M. Conaway,et al. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol. , 2002, Endocrinology.
[25] S. Langdon,et al. Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’) , 2002, British Journal of Cancer.
[26] R. Nicholson,et al. EGFR and cancer prognosis. , 2001, European journal of cancer.
[27] I. Ellis,et al. Phosphorylation of ERK1/2 mitogen‐activated protein kinase is associated with poor response to anti‐hormonal therapy and decreased patient survival in clinical breast cancer , 2001, International journal of cancer.
[28] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[29] J. Thomsen,et al. Mechanisms of estrogen action. , 2001, Physiological reviews.
[30] G. Tortora,et al. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] Yue Sun,et al. β-Arrestin Differentially Regulates the Chemokine Receptor CXCR4-mediated Signaling and Receptor Internalization, and This Implicates Multiple Interaction Sites between β-Arrestin and CXCR4* , 2000, The Journal of Biological Chemistry.
[32] R. Lefkowitz,et al. Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade , 1999, The Journal of Biological Chemistry.
[33] J. York,et al. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Davie,et al. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. , 1999, Molecular biology of the cell.
[35] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[36] Kouji Matsushima,et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.
[37] G. Nuovo,et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.
[38] Alessandro Massa,et al. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta. , 2007, Molecular endocrinology.
[39] G. Schettini,et al. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. , 2007, Neuro-oncology.
[40] R. Bonavia,et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.
[41] A. Yang,et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo , 2005, Cancer Gene Therapy.
[42] N. Warrington,et al. Widespread CXCR 4 Activation in Astrocytomas Revealed by Phospho-CXCR 4-Specific Antibodies , 2005 .
[43] I. Ellis,et al. Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy , 2004, Breast Cancer Research and Treatment.
[44] H. Yao,et al. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). , 1999, Molecular endocrinology.